Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The host DNA replication and transcription machinery is a sophisticated network of enzymes and regulatory proteins, including DNA polymerases, RNA polymerases, helicases, and topoisomerases, that facilitate the duplication of the genome and the synthesis of RNA (Source: Nature Reviews Molecular Cell Biology). These processes are fundamental to cellular life, ensuring the faithful transmission of genetic information and the execution of gene expression programs (Source: Molecular Biology of the Cell). In the context of infectious diseases, many viruses lack their own biosynthetic enzymes and must hijack the host's machinery to replicate their viral genomes and transcribe viral mRNA (Source: Microbiology and Molecular Biology Reviews). Consequently, components of this machinery are often targeted by broad-spectrum antiviral strategies and, more commonly, by oncology therapeutics. Drugs such as antimetabolites like Cytarabine and topoisomerase inhibitors like Etoposide disrupt these processes to arrest the growth of rapidly dividing cancer cells (Source: StatPearls). Transcription inhibitors like Actinomycin D prevent the synthesis of RNA by intercalating into DNA and blocking the movement of RNA polymerase (Source: PubChem). However, because these targets are essential for normal cell function, drugs affecting the host machinery frequently exhibit significant systemic toxicity, such as myelosuppression and mucosal inflammation (Source: NIH, National Cancer Institute). Understanding the specific interactions between pathogens and host machinery remains a critical area for developing host-directed therapies that aim to minimize resistance (Source: Frontiers in Microbiology).
Inhibition of DNA and RNA polymerases, DNA intercalation, and stabilization of topoisomerase-DNA cleavage complexes to prevent replication and transcription (Source: StatPearls; Nature Reviews Cancer).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host DNA replication and transcription machinery.